{"id":"W4211150554","doi":"10.3390/curroncol29020080","title":"Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Nausea; Metastatic Urothelial Carcinoma; Adverse effect; Tolerability; Retrospective cohort study; Clinical endpoint; Cohort; Clinical trial; Surgery; Oncology; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003946814,0.0003985862,0.0006831543,0.000539859,0.0003674107,0.0004889127,0.0003101468,0.0004064973,0.002177799],"category_scores_gemma":[0.003278891,0.0001574894,0.0006929507,0.0005240284,0.0004146085,0.0003744944,0.0005171726,0.0002575665,0.0003578552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006706173,"about_ca_system_score_gemma":0.0004552949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004337032,"about_ca_topic_score_gemma":0.0003269509,"domain_scores_codex":[0.9981862,0.001033342,0.0001485028,0.0002880938,0.0002117935,0.0001321136],"domain_scores_gemma":[0.9964339,0.0006351722,0.001633298,0.0004401285,0.0003772071,0.0004802515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05229367,0.006963542,0.8507159,0.0008375454,0.002281634,0.0009258333,0.0006517021,0.001258521,0.01204819,0.0002375479,0.001163709,0.0706222],"study_design_scores_gemma":[0.006425044,0.03693617,0.9458685,0.00006975852,0.0007773673,0.00293939,0.0002172896,0.000987844,0.001482752,0.00008099086,0.004176544,0.00003839803],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979101,0.001113673,0.0001967004,0.00003288809,0.000004455191,0.0001177613,0.0002027983,0.000005156342,0.0004166073],"genre_scores_gemma":[0.9988979,0.0003244992,0.0001947754,0.00005865758,0.00003186503,0.00008083705,0.0003166236,0.000002848415,0.00009196206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003946814,"threshold_uncertainty_score":0.02087301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08305809235798994,"score_gpt":0.4483409670874947,"score_spread":0.3652828747295048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}